Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?. Issue 4 (9th February 2022)

Record Type:: Journal Article
Title:: Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?. Issue 4 (9th February 2022)
Main Title:: Does the FDA‐approved Alzheimer drug aducanumab have a place in the Australian pharmacopoeia?
Authors:: Gleason, Andrew
Ayton, Scott
Bush, Ashley I
Abstract:
Is Part Of:: Medical journal of Australia. Volume 216:Issue 4(2022)
Journal:: Medical journal of Australia
Issue:: Volume 216:Issue 4(2022)
Issue Display:: Volume 216, Issue 4 (2022)
Year:: 2022
Volume:: 216
Issue:: 4
Issue Sort Value:: 2022-0216-0004-0000
Page Start:: 172
Page End:: 174
Publication Date:: 2022-02-09
Subjects:: Alzheimer disease -- Therapeutic Goods Administration -- Clinical trials as topic -- Dementia
Medicine -- Periodicals
Medicine
Médecine -- Périodiques
Medicine
Periodical
Periodicals
Electronic journals
610
Journal URLs:: https://onlinelibrary.wiley.com/journal/13265377 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.5694/mja2.51408 ↗
Languages:: English
ISSNs:: 0025-729X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5529.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21038.xml